![Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/95258a36-f559-4d4f-b6a8-f51b1a2802ca/gr1a_lrg.jpg)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet
![PDF) All One Needs to Know about Metaverse: A Complete Survey on Technological Singularity, Virtual Ecosystem, and Research Agenda PDF) All One Needs to Know about Metaverse: A Complete Survey on Technological Singularity, Virtual Ecosystem, and Research Agenda](https://i1.rgstatic.net/publication/355172308_All_One_Needs_to_Know_about_Metaverse_A_Complete_Survey_on_Technological_Singularity_Virtual_Ecosystem_and_Research_Agenda/links/619c4bc5d7d1af224b199c8d/largepreview.png)
PDF) All One Needs to Know about Metaverse: A Complete Survey on Technological Singularity, Virtual Ecosystem, and Research Agenda
![Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c5ce84c4-2996-4e43-9e4d-5447ad0ccc66/gr1_lrg.jpg)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Scaled, high fidelity electrophysiological, morphological, and transcriptomic cell characterization | eLife Scaled, high fidelity electrophysiological, morphological, and transcriptomic cell characterization | eLife](https://iiif.elifesciences.org/lax:65482%2Felife-65482-fig6-figsupp2-v2.tif/full/,1500/0/default.jpg)
Scaled, high fidelity electrophysiological, morphological, and transcriptomic cell characterization | eLife
![White Space Is Not Your Enemy: A Beginner's Guide to Communicating Visually Through Graphic, Web & Multimedia Design: Golombisky, Kim, Hagen, Rebecca: 9781138804647: Amazon.com: Books White Space Is Not Your Enemy: A Beginner's Guide to Communicating Visually Through Graphic, Web & Multimedia Design: Golombisky, Kim, Hagen, Rebecca: 9781138804647: Amazon.com: Books](https://images-na.ssl-images-amazon.com/images/I/71c6zFACPAL._AC_UL600_SR600,600_.jpg)
White Space Is Not Your Enemy: A Beginner's Guide to Communicating Visually Through Graphic, Web & Multimedia Design: Golombisky, Kim, Hagen, Rebecca: 9781138804647: Amazon.com: Books
![Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems | Nature Communications Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22330-w/MediaObjects/41467_2021_22330_Fig1_HTML.png)
Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems | Nature Communications
![Is South Korea Going Global? New Possibilities Together With the Biden Administration - Carnegie Endowment for International Peace Is South Korea Going Global? New Possibilities Together With the Biden Administration - Carnegie Endowment for International Peace](https://images.carnegieendowment.org/images/article_images/202107-KSR_Figure1_a2a4d99d-53c3-4555-a042-ff17653df012.png)
Is South Korea Going Global? New Possibilities Together With the Biden Administration - Carnegie Endowment for International Peace
![Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants - The Lancet Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/67a90257-604e-4b15-ba90-4cd5b7e108a6/gr1.jpg)